EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic, Germany, Italy and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
University Hospitals Leuven
Belgium
1. Current Status, Position
As Chief Medical Technology Officer Prof Dr Frank Rademakers (MD, PhD) is responsible for the diagnostic departments of the hospital (radiology, nuclear medicine, pathology, forensic medicine, medical genetics and laboratory medicine) as well as for the Pharmacy and IT. He has an overall responsibility for innovation and as such supports the contacts with external partners in research and industry.
Trained as a cardiologist Prof Dr Rademakers spent 2.5 years at the Johns Hopkins Hospital in Maryland, USA working in cardiac physiology and imaging. He worked as a consultant cardiologist at the University Hospital in Antwerp before moving to the KU Leuven in 1998. After 7 years in the clinical department of cardiology, he became medical director of the hospital until 2015 when he moved into his current position. During this 10 year period as medical director Prof Dr Frank Rademakers was very much involved with the first JCI accreditation of the hospital in 2010 and it’s reaccreditation in 2013.
2. Education
Prof Dr Frank Rademakers completed his medical studies at the University of Antwerp in 1979. He then trained as a cardiologist between 1979 and 1984 in Antwerp. Besides this Board certification in cardiology he also obtained a Board certification in Cardiac Rehabilitation in 1985 and in that same year the FMGEMS certificate. Prof Dr Rademakers acquired a degree in Sports Medicine from the KU Leuven in 1986. In 1991 he was awarded a PhD degree by the University of Antwerp.
3. Research Area
Prof Dr Rademakers’ research interest is primarily in cardiac physiology and imaging using echocardiography and magnetic resonance imaging. More specifically the topic is left ventricular mechanics and perfusion, mainly in ischemic heart disease. In line with his function of medical director the accreditation process another area of research developed regarding organization of health care both as processes within the hospital (OR, medication) and more generally about health care systems and quality. While the latter area was developed mainly practically and educationally, Prof Dr Rademakers added several publications in this field to the 100+ peer reviewed publications in cardiology and physiology.
4. Conflict of interest: none
